Table 4. Estimated number of chronic disease in insured adults (≥20 year old) and number of insured who utilized health services in the past year, by health institution.
| Adults prevalence (A) | % of adults who utilized consultations in the year (B) | Estimated adults with chronic disease*C = (A) x (adults beneficiaries) | Estimated adults who utilized medical consultationD = (C) x (B) | Estimated adults who utilized laboratory and other tests**E = (D) x (% of beneficiaries who reported use of laboratory and other tests) | Estimated adults who utilized drugs**F = (D) x (% of beneficiaries who reported use of drugs) | Estimated adults who utilized hospitalization in the year***G = (C) x (% of beneficiaries who reported use of hospitalization) | Information source for prevalence and utilization of medical consultations | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chronic disease | Both health institutions | Both health institutions | MoH | IMSS | MoH | IMSS | MoH | IMSS | MoH | IMSS | MoH | IMSS | Prevalence | Consultations |
| Arterial hypertension | 32% | 69% | 9,288,968 | 7,306,804 | 6,409,388 | 5,041,695 | 1,666,441 | 1,865,427 | 5,896,637 | 4,688,776 | 464,448 | 438,408 | [9] | [63] |
| Gastritis | 31% | 13% | 9,112,036 | 7,167,626 | 1,184,565 | 931,791 | 296,141 | 335,445 | 1,149,028 | 885,202 | 455,602 | 358,381 | [59] | [64] |
| Type 2 diabetes | 9% | 87% | 2,704,122 | 2,127,092 | 2,339,065 | 1,839,934 | 1,052,579 | 1,011,964 | 2,151,940 | 1,692,740 | 162,247 | 148,896 | [60] | ENSANUT |
| Irritable bowel syndrome | 16% | 20% | 4,718,206 | 3,711,392 | 943,641 | 742,278 | 386,893 | 141,033 | 887,023 | 705,165 | 141,546 | 185,570 | [34] | [64] |
| Depressive disorder | 11% | 20% | 3,161,198 | 2,486,633 | 619,595 | 487,380 | 136,311 | 82,855 | 551,439 | 448,390 | 189,672 | 149,198 | ENSANUT | [65] |
| Chronic kidney disease**** | 8% | 36% | 2,359,103 | 1,855,696 | 839,841 | 660,628 | 419,920 | 455,833 | 722,263 | 660,628 | 377,456 | 649,494 | [62,67] | [67] |
| Osteoarthritis | 11% | 25% | 3,096,323 | 2,435,601 | 770,984 | 606,465 | 192,746 | 388,137 | 770,984 | 497,301 | 185,779 | 97,424 | [58] | [68] |
| Chronic ischemic heart disease | 3% | 40% | 807,993 | 635,576 | 323,197 | 254,230 | 161,599 | 134,742 | 323,197 | 238,977 | 145,439 | 152,538 | ENSANUT | [69] |
| Asthma | 5% | 46% | 1,503,928 | 1,183,006 | 687,295 | 540,634 | 213,062 | 362,225 | 632,312 | 448,726 | 135,354 | 94,641 | [61] | [66] |
| Total | 36,751,877 | 28,909,427 | 14,117,572 | 11,105,036 | 4,525,692 | 4,777,661 | 13,084,823 | 10,265,903 | 2,257,544 | 2,274,550 | ||||
Source: Own processing. Notes: CD = chronic disease; CKD = chronic kidney disease; ENSANUT: Mexican National Health and Nutrition Survey;
* = MoH adults population coverage = 29.4 million; IMSS population coverage = 23.1 million;
** = based on information located in Table 1;
*** = based on information located in Table 2;
**** = 3% of the adults (both health institutions) with CKD are undergoing dialysis (Secretaría de Salud de Mexico (2014) Tratamiento sustitutivo de la función renal. Diálisis y hemodiálisis en la insuficiencia renal crónica. México: SS. 59 p.) For MoH 75,963 insured are under kidney dialysis, in the case of IMSS the insured are 59,753.